The unit of analysis error in studies about physicians' patient care behavior
The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
Objective To estimate the frequency with which patients are incorrectly used as the unit of analysis among statistical calculations in published studies of physicians' patient care behavior. Design Retrospective review of studies published during 1980-1990. ARTICLES: 54 articles retrieved by a computerized search using medical subject headings for physicians and study characteristics. Article selection criteria included the requirement that the physician should have been the correct unit of analysis. Intervention Presence of the error was determined by consensus using published criteria. Main results The error was present in 38 articles (70%). The number of study physicians was reported in 35 articles (65%). The error was found in 57% of articles that reported the number of study physicians and in 95% of those that did not. The error rate was not lower among articles published more recently nor among those published in journals with higher rates of article citations in the medical literature. Conclusion The unit of analysis error occurs frequently and can generate artificially low p values. Failure to report the number of study physicians can be a clue that this type of error has been made.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Authors often fail to account for intraclass correlation in clustered studies, leading to a 'unit of analysis' error (Divine 1992), whereby P values are spuriously low, CIs unduly narrow and statistical significance overestimated.”
From Compulsory community and involuntary outpatient treatment for people with severe mental disorders. (2017) · cites this paper as Divine 1992
Citations
Cites
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
SCHEFFE, H. (1960) · Soil Science · doi:10.1097/00010694-196006000-00016 · Cited by 5,516
Some statistical methods useful in circulation research.
Wallenstein, S., Zucker, C. L., & Fleiss, J. L. (1980) · Circulation Research · doi:10.1161/01.res.47.1.1 · Cited by 3,886
Freiman, J. A., Chalmers, T. C., Smith, H., & Kuebler, R. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197809282991304 · Cited by 1,628 · cited 3×
“1980 2 (4) 2 (100) 2 (100) 2 ( 1 O0 1981 0 - - - 1982 6 ( 11 ) 5 (83) 2 (33) 4 (67) 1983 5 (9) 4 (80) 3 (60) 3 (60) 1984 6 (11) 5 (83) 5 (83) 3 (50) 1985 5 (9) 4 (80) 4 (80) 3 (60) 1986 4 (7) 4 (100) 2 (50) 3 (75) 1987 9 (17) 7 (78) 5 (56) 7 (78) 1988 4 (7) 3 (75) 3 (75) 3 (75) 1989 11 (20) 11 (100) 7 (64) 8 (73) 1990…”
Comparing the Means of Several Groups
Godfrey, K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132305 · Cited by 737
Statistical Problems in the Reporting of Clinical Trials
Pocock, S. J., Hughes, M. D., & Lee, R. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170706 · Cited by 662 · cited 1×
“1980 2 (4) 2 (100) 2 (100) 2 ( 1 O0 1981 0 - - - 1982 6 ( 11 ) 5 (83) 2 (33) 4 (67) 1983 5 (9) 4 (80) 3 (60) 3 (60) 1984 6 (11) 5 (83) 5 (83) 3 (50) 1985 5 (9) 4 (80) 4 (80) 3 (60) 1986 4 (7) 4 (100) 2 (50) 3 (75) 1987 9 (17) 7 (78) 5 (56) 7 (78) 1988 4 (7) 3 (75) 3 (75) 3 (75) 1989 11 (20) 11 (100) 7 (64) 8 (73) 1990…”
Statistics with applications to the biological and health sciences
Remington, R. D., & Schork, M. A. (1970) · Medical Entomology and Zoology · Cited by 521
Central Vein Catheterization: Failure and Complication Rates by Three Percutaneous Approaches
Sznajder, J. I. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360140065007 · Cited by 496
A Randomized Trial of Continuing Medical Education
Sibley, J. C., Sackett, D. L., Neufeld, V., Gerrard, B., Rudnick, K. V., & Fraser, W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203043060904 · Cited by 342
A Randomized Trial of a Family Physician Intervention for Smoking Cessation
Wilson, D. M. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410110078031 · Cited by 239
Research works printed but not linked: 1
- Snedecor GW, Cochran WG. Statistical methods, 7th ed. Ames, IA: Iowa State University Press, 1980.
Cited by
Items 601–700 of 750
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
Boso, M., Cipriani, A., & Barbui, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006324 · Cited by 3
Psychoeducation for the parents of people with severe mental illness
Cuesta‐Lozano, D., López‐Alcalde, J., Molina, F. J. C., García-Sastre, M., Herrera, P. M., Muriel, A., Esteve, Á. L. A., Díaz, N. Á., Martín, D. M., & Montero, A. C. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014532 · Cited by 2
Aripiprazole versus brexpiprazole for people with schizophrenia
Martínez-Vélez, N. A., Escamilla-Orozco, R. I., Flores-Medina, Y., Saracco-Álvarez, R. A., Rosel-Vales, M., Salas, I. A., & Hernández, G. Y. S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014670 · Cited by 2
Post-incident debriefing for people with schizophrenia after coercive measures
Valimaki, M. A., Varpula, J., & Lantta, T. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014487.pub2 · Cited by 2
Aspirin dosage for the prevention of graft occlusion in people undergoing coronary surgery
Alahdab, F., Jazayerli, M. L., Alhalabi, O., Hasan, S. M., Mallak, M., Alkhouli, M. A., Haydour, Q., & Murad, M. H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012113 · Cited by 3
RetractedCelecoxib plus standard care for people with schizophrenia
Kotecha, A., & Upthegrove, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009205.pub2 · Cited by 2
“Divine 1992 Divine GW, Brown JT, Frazier LM.”
BackgroundNidotherapy for people with schizophrenia
Chamberlain, I. J., & Sampson, S. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009929.pub2 · Cited by 3
Specialist interventions for homeless people with severe mental illness
Essali, A., Tarboush, M., & Awad, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010170 · Cited by 2
Takeshima, N., Furukawa, T. A., Hayasaka, Y., Ogawa, Y., & Tajika, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011049 · Cited by 2
Monetary incentives for schizophrenia
Michalczuk, R., & Mitchell, A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007626.pub2 · Cited by 2
Olanzapine discontinuation for schizophrenia
Alahdab, F., Alhalabi, O., Attwa, G., Basha, G. M., & Adams, C. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009693 · Cited by 2
Anticholinergics (various) for neuroleptic-induced parkinsonism
Dickenson, R., Bethi, S., & Srivastava, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011113 · Cited by 2
Clozapine for persistent aggressive behaviour or agitation in people with schizophrenia
Ostinelli, E. G., Zangani, C., & Solmi, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013493 · Cited by 3
Typical antipsychotics for psychosis in adolescents
Datta, S. S., Kumar, A., Wright, S., & Russell, P. S. S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009539 · Cited by 3
Cognitive behavioural therapy without medication for schizophrenia
Bighelli, I., Çıray, O., & Leucht, S. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015332 · Cited by 2
Post-incident debriefing for people with schizophrenia after coercive measures
Valimaki, M. A., Varpula, J., & Lantta, T. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014487 · Cited by 2
Interventions for psychosis in adolescents
Wright, S. D., & Russell, P. S. S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004965 · Cited by 2
Relapse prevention for schizophrenia
Vidgen, A., Hughes, I., & Roberts, N. P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009767 · Cited by 2
Interventions for antipsychotic-induced amenorrhoea
Ravan, J. R., & Dholakia, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012452 · Cited by 3
Non-clozapine antipsychotic combinations for treatment-resistant schizophrenia
Yow, A., & Jayaram, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012523 · Cited by 2
Fluphenazine (dose) for people with schizophrenia
Turk, T., Yafi, R. Z., Namous, L. O., Alkhaledi, A. N., Salahia, S. I., Haider, A. Y., & Essali, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012848 · Cited by 2
Karl, B., Bergman, H., Sayed, S. A. E., & Adams, C. E. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012986 · Cited by 2
Routine outcome assessment for depression and anxiety
Gilbody, Sm, House, Ao, Sheldon, & Ta (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002792 · Cited by 2
Second-generation antipsychotic drugs for major depressive disorder
Komossa, K., Depping, A. M., Kissling, W., & Leucht, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008121 · Cited by 2
S-adenosyl methionine (SAM-e) for depression in adults
Galizia, I., Oldani, L., Macritchie, K., Amari, E., Dougall, D., Jones, T. N., Lam, R. W. M., Massei, G. J., Yatham, L. N., & Young, A. H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011286 · Cited by 2
Franceschi, S., & Plummer, M. (2005) · Springer eBooks · doi:10.1007/3-540-26577-5_9 · Cited by 3
Twenty-four hour care for schizophrenia
Macpherson, R., Chilvers, R., & Elliot, H. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004409 · Cited by 2
Paliperidone palmitate for schizophrenia
Nussbaum, A. M., & Stroup, T. S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008296 · Cited by 2
Essali, A., RIHAWI, A., Sharaf, M., Altujjar, M., Alhafez, B., Tarboush, A., & Hasan, N. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009546 · Cited by 2
Self-management programme for ankylosing spondylitis
Felix, L. M., & Montgomery, P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006977 · Cited by 2
Treatments for delusional disorder
Skelton, M., Khokhar, W. A., & Thacker, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009785 · Cited by 2
Aripiprazole versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel‐Kluge, C., Schmidt, F., Hunger, H., Schwarz, S., El-Sayeh, H. G. G., Kissling, W., & Leucht, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006569.pub2 · Cited by 2
Papageorgiou, A., Loke, Y. K., Deane, K. H., & Fromage, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010006 · Cited by 2
Brief family intervention for schizophrenia
Okpokoro, U., & Adams, C. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009802 · Cited by 2
Bifeprunox versus placebo for schizophrenia
Chattopadhyay, A., Frey, S., Green, G., Harkness, A., McDermott, A., & Yates, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012029 · Cited by 2
Valimaki, M. A., Kauppi, K., Hätönen, H. M., Kuosmanen, L., Warwick-Smith, K., & Adams, C. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009960 · Cited by 2
Samara, M. T., Kottmaier, E., Helfer, B., Leucht, C., Christodoulou, G. N., Huhn, M., Rothe, P., Schneider‐Thoma, J., & Leucht, S. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011885.pub2 · Cited by 8
Brooks‐Gordon, B. (2010) · BIROn (Birkbeck, University of London) · Cited by 1
Enhanced crisis planning for serious mental illness
Savage, R., Singh, J. A., Bhoskar, S. U., & Jayaram, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009482 · Cited by 1
Aripiprazole for neuroleptic induced hyperprolactinaemia
Kolli, V. B., Bestha, D. P., Madaan, V., & Byreddy, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010786 · Cited by 1
Antipsychotics for people with persistent negative symptoms of schizophrenia
Whittington, C. J., Barnes, T. R. E., & Kendall, T. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008406 · Cited by 1
Allopurinol and related drugs for schizophrenia
Akhondzadeh, S., Modabbernia, A., Hosseini, S. M., & Tajdini, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009563 · Cited by 1
Iloperidone versus placebo for schizophrenia
Sawan, M., Nayfeh, T., Majzoub, A. M., Alabaji, H., Alnahas, S., Saadi, T. A., & Essali, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011838 · Cited by 1
Amphetamines versus placebo for schizophrenia
Essali, N., Isstaif, J., Al-Baghdadi, R., Yousef, B. A. A. A., & Mheish, A. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011868 · Cited by 1
Self-management programme for ankylosing spondylitis (Protocol)
Felix, L. M., & Montgomery, P. (2008) · Cited by 2
Mirtazapine (adjunct) versus placebo for schizophrenia
Stricklin, S. M., Perry, L. A., & Ramson, D. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011943 · Cited by 1
Collaborative care approaches for people with severe mental illness (Protocol)
Reilly, S., Planner, C., Knowles, S. R., Gask, L., Hann, M., Druss, B. G., & Lester, H. E. (2012) · Cochrane Database of Systematic Reviews · Cited by 2
Lurasidone versus typical antipsychotics for schizophrenia
Datka, W., Jaeschke, R. R., Styczeń, K., Koperny, M., Waligóra, M., Hubert, J., & Storman, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012429 · Cited by 1
Chlorpromazine versus thiothixene for people with schizophrenia
Cardoso, D., Wakeham, J., Shaw, P. A., Dutton, B., & Wildman, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012790 · Cited by 1
Adjunctive Peony-Glycyrrhiza Decoction for antipsychotic-induced hyperprolactinemia
Li, X., Zhao, L., Bo, Q., Zhou, F., Li, B., & Wang, C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012422 · Cited by 1
Blonanserin versus risperidone for schizophrenia
Turk, T., Morfin, N. H., & Alkhatib, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012587 · Cited by 2
Clozapine versus quetiapine for people with schizophrenia
Lobos, C. A., Fonseca, C., Leucht, S., García-Ribera, C., & Cortés-Jofré, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013220 · Cited by 1
Transitional discharge interventions for people with serious mental illness
Rodríguez, P. R., Franco, J. V. A., Garegnani, L., Arancibia, M., Liquitay, C. M. E., & Mohammad, H. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009788.pub2 · Cited by 2
Cognitive behavioural therapy plus standard care for first episode psychosis
Bighelli, I., Corcoran, C., Umama-Agada, E., & Leucht, S. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015331 · Cited by 1
Placebo versus no treatment for people with schizophrenia
Takeuchi, H., Shimomura, Y., Kikuchi, Y., Nomura, N., Hird, E., Wu, H., Agid, O., & Leucht, S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015403 · Cited by 1
Valimaki, M. A., Hätönen, H. M., Adams, C. E., Arifulla, D., Kostiainen, J., & Kostamo, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009766 · Cited by 1
Sulpiride dose for schizophrenia
Rezk, E., Mohammad, H. A., Refaï, T., & Mashoosh, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009846 · Cited by 1
Kour, K., Kaur, R., & Singh, J. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010552 · Cited by 1
Aripiprazole for people with schizophrenia whose illness has been partially responsive to clozapine
Assalman, I., Makhoul, S., & Hussain, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009847 · Cited by 1
Anticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesia
Momčilović, S., Dickenson, R., & Adams, C. E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011262 · Cited by 1
Ashraf, M. S., Javed, Z., & Kumar, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011035 · Cited by 1
Switching antipsychotic for non response in schizophrenia
Helfer, B., Rothe, P., Leucht, S., & Samara, M. T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011885 · Cited by 1
Vilazodone for major depressive disorder in adults
Song, L., Liu, Y., Liu, F., Zhang, R., Ji, H., & Jia, Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012350 · Cited by 1
Ginkgo biloba versus placebo for schizophrenia
Deng, H., Xu, J., & Yeung, W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012524 · Cited by 2
Magnetic seizure therapy for people with schizophrenia
Wu, H., Jiang, J., Wang, J., Cao, X., & Li, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012697 · Cited by 1
Elbourne, D. R. (2012) · Cited by 1
Aripiprazole versus ziprasidone for schizophrenia
Yang, H., Zheng, J., Li, B., Zhao, S., & Zheng, W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012811 · Cited by 2
Lloyd, J., Valimaki, M. A., & Ho, G. W. K. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012844 · Cited by 1
Humour-based interventions for people with schizophrenia
Kohmura, K., Banno, M., Tsujimoto, H., Tsujimoto, Y., & Kataoka, Y. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013367 · Cited by 1
Psychological interventions for psychosis in adolescents
Wright, S., Datta, S. S., & Kumar, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009533 · Cited by 1
Electroconvulsive therapy for treatment-resistant schizophrenia
Sinclair, D. J., Ellison, J. M., & Adams, C. E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011847 · Cited by 3
Treatment delivery using information and communication technology for people with schizophrenia
Valimaki, M. A., Hätönen, H. M., Jakobsson, T., Kaur, S., & Kuosmanen, L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007198 · Cited by 2
Dietary advice for schizophrenia
Pearsall, R., Pelosi, A. J., & Geddes, J. R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009547 · Cited by 1
Second-generation antipsychotic drugs for anxiety disorders
Depping, A. M., Komossa, K., Kissling, W., & Leucht, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008120 · Cited by 2
Dornan, S., Abel, W., & Wong, D. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004837 · Cited by 1
Appraising covariate balance after assignment to treatment by groups Technical Report # 436
Hansen, B. B. (2006) · Cited by 1
randomised trials CONSORT statement: extension to cluster
Campbell, M., Elbourne, D. R., & Altman, D. G. (2006) · Cited by 1
Dance therapy for schizophrenia
Xia, J., & Grant, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006868 · Cited by 1
Acetylcholinesterase inhibitors for schizophrenia
Singh, J. A., Kour, K., & Jayaram, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007967 · Cited by 1
Glutamatergic drugs for schizophrenia
Tuominen, H. J., Wahlbeck, K., & Tiihonen, J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003730 · Cited by 2
Clozapine dose for schizophrenia
Subramanian, S., & Vӧllm, B. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009555 · Cited by 2
Chlorpromazine for psychosis induced aggression or agitation
Gul, M., Ahmed, U., & Adams, C. E. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007445 · Cited by 1
Atypical antipsychotics for people with both schizophrenia and depression
Furtado, V. A., & Srihari, V. H. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005377 · Cited by 1
Antipsychotic medication for early episode schizophrenia
Bola, J. R., & Soydan, H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006374 · Cited by 1
Zuclopenthixol versus placebo for schizophrenia
Lacey, M., Jayaram, M., & Esbensen, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010598 · Cited by 1
Leucht, S., & Hartung, B. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003083 · Cited by 1
Zotepine versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel‐Kluge, C., Hunger, H., Schmidt, F., Schwarz, S., Kissling, W., & Leucht, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006628 · Cited by 1
Distraction techniques for schizophrenia
Crawford-Walker, C., King, A., & Chan, S. K. W. (2003) · doi:10.1002/14651858.cd004717 · Cited by 1
Intermittent drug techniques for schizophrenia
Mansour, M., Alomar, A., Boubes, K. Y., & Mouchli, M. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006196 · Cited by 1
Trifluoperazine versus placebo for schizophrenia
Koch, K., Mansi, K., Haynes, E., & Adams, C. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010226 · Cited by 1
A cluster randomised controlled trial of Pharmacist-led Statin Outreach Support in Primary Care
Lowrie, R. (2012) · Enlighten: Theses (The University of Glasgow)
Borschmann, R., Khalifeh, H., Trevillion, K., Howard, L. M., & Moran, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011042
Chua, W., de Izquierdo, S. A., Kulkarni, J., & Mortimer, A. M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004719
Rehabilitation programmes for schizophrenia
Makhoul, S., Adams, C. E., & Balain, V. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007301
Carter, K., Ojo, R., & Saczawa, M. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006720.pub2
Mood stabilisers for schizoaffective disorder
Ahmed, R. I., Namboodiri, V., & Tahira, F. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009474 · Cited by 1
Postdischarge interventions for depression
Nilsson, M., Lindschou, J., Jakobsen, J. C., & Arnfred, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011591
Aripiprazole dose for schizophrenia
Thiyagarajan, S., & Sivaraman, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009800
Effects of telemonitoring in patients with heart failure
Boyne, J. J. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131213jb
Duloxetine for generalised anxiety disorder (GAD)
Carter, K., McKibben-Sanders, J., Nunez, A., & Trotman, H. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008339.pub2
Metadata
- Authors
- Divine, G. W., Brown, J. T., & Frazier, L. M.
- Affiliations
- Duke University (US)
- Venue
- Journal of General Internal Medicine
- Published
- 1992-11
- Volume
- 7
- Issue
- 6
- Pages
- 623-629
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- OpenAlex
- W2058874144
- Cited by
- 749
- References
- 67
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 12 · 2023: 9 · 2022: 16 · 2021: 6 · 2020: 12 · 2019: 27 · 2018: 36 · 2017: 37 · 2016: 47 · 2015: 47 · 2014: 46 · 2013: 50 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of General Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Health Sciences › Nursing › Research and Theory › Methodologies in Health Research and Practice
- Keywords
- statistical reporting errors, methodological quality
- MeSH terms
- Data Interpretation, Statistical, Health Services Research, Humans, Medical Audit, Physicians, Retrospective Studies, Subject Headings, MEDLINE, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.